Advertisement
Research Article

Trastuzumab in the Adjuvant Treatment of HER2-Positive Early Breast Cancer Patients: A Meta-Analysis of Published Randomized Controlled Trials

  • Wenjin Yin equal contributor,

    equal contributor Contributed equally to this work with: Wenjin Yin, Yiwei Jiang

    Affiliation: Department of Breast Surgery, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China

    X
  • Yiwei Jiang equal contributor,

    equal contributor Contributed equally to this work with: Wenjin Yin, Yiwei Jiang

    Affiliation: Department of Breast Surgery, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China

    X
  • Zhenzhou Shen,

    Affiliation: Department of Breast Surgery, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China

    X
  • Zhimin Shao,

    Affiliation: Department of Breast Surgery, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China

    X
  • Jinsong Lu mail

    lujjss@yahoo.com.cn

    Affiliation: Department of Breast Surgery, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China

    X
  • Published: June 09, 2011
  • DOI: 10.1371/journal.pone.0021030

Viewed info

Cited info

Saved info

Discussed info

Questions or concerns about usage data? Please let us know.